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Abstract
Background: Comparing patterns of resource utilization between hospitals is often complicated by biases in
community and patient populations. Stroke patients treated with tissue plasminogen activator (tPA) provide a
particularly homogenous population for comparison because of strict eligibility criteria for treatment. We tested
whether resource utilization would be similar in this homogenous population between two hospitals located in a
single Midwestern US community by comparing use of diagnostic testing and associated outcomes following
treatment with t-PA.
Methods: Medical records from 206 consecutive intravenous t-PA-treated stroke patients from two teaching
hospitals (one university, one community-based) were reviewed. Patient demographics, clinical characteristics and
outcome were analyzed, as were the frequency of use of CT, MRI, MRA, echocardiography, angiography, and EEG.
Results: Seventy-nine and 127 stroke patients received t-PA at the university and community hospitals,
respectively. The two patient populations were demographically similar. There were no differences in stroke
severity. All outcomes were similar at both hospitals. Utilization of CT scans, and non-invasive carotid and cardiac
imaging studies were similar at both hospitals; however, brain MR, TEE, and catheter angiography were used more
frequently at the university hospital. EEG was obtained more often at the community hospital.
Conclusions: Utilization of advanced brain imaging and invasive diagnostic testing was greater at the university
hospital, but was not associated with improved clinical outcomes. This could not be explained on the basis of
stroke severity or patient characteristics. This variation of practice suggests substantial opportunities exist to reduce
costs and improve efficiency of diagnostic resource use as well as reduce patient exposure to risk from diagnostic
procedures.
Background
Stroke is a leading cause of death and disability in the
United States as well as throughout developed coun-
tries world-wide. Every year, there are approximately
700,000 new or recurring strokes in the United States,
with one in 16 deaths in 2004 being attributed to
stroke [1]. The overall direct and indirect costs asso-
ciated with stroke in the United States alone are
estimated at $62.7 billion in 2007 [1]. Of this, approxi-
mately 18 billion dollars is expected to go toward
direct in-hospital costs, not including physician fees or
medications [1].
Diringer and colleagues [2] examined the breakdown
of hospital costs in 191 individuals presenting with
acute ischemic stroke to a single tertiary care academic
hospital. These researchers estimated 50% of costs were
attributed to bed charges (16% ICU, 34% ward). An
additional 19% (approximately $3.5 billion in 2007) were
associated with diagnostic tests. Reed [3] argued that
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rately as costs can differ dramatically between facilities.
For example, these researchers found that costs in
teaching community hospitals were 10-30% greater than
those at non-teaching community hospitals. Further-
more, they estimated that, overall, community hospital
costs were approximately 10-20% lower than academic
medical center costs.
Variability in spending by hospital type is likely to be
a reflection of variability in practice, particularly with
regard to the use of diagnostic tests. Practice variability
is common for all diagnoses, and studying variability is
often used as an approach to improving quality of care
or to reducing expense. Evaluation of practice variability
is, however, confounded by local referral patterns or dif-
ferences in the patient populations served by different
doctors and different facilities. Variability in patient
populations including differences in age, disease severity,
acuity, and comorbidities are potential confounders that
make examining practice variability even more difficult.
In stroke care in particular, differences in patients’ ages,
comorbidities, and stroke severity may distinguish
patients treated in tertiary care hospitals from those
treated in community hospitals.
Many studies of economic burden associated with
stroke [4-6] group all types of stroke (including subar-
achnoid hemorrhage, intracerebral hemorrhage and
transient ischemic attacks) with ischemic stroke. Reed
and colleagues [3] argued that it is important to break
stroke subtypes down by category as different types of
strokes would be associated with different lengths of
stay (LOS) and different hospital procedures, leading to
significantly differing costs. These researchers calculated
that, in 1998, the average per incident inpatient costs
was approximately $5837 specifically for ischemic
stroke.
In our community, stroke patients from a tri-county
area are treated in two large tertiary care teaching hos-
pitals. Both hospitals draw from the same population
base, and are served by the same emergency medical
system (EMS). By virtue of their condition and the
imposition of a narrow treatment window, acute stroke
patients treated with t-PA are unlikely to be influenced
by differences in hospital referral patterns, and are likely
similar with regard to stroke severity, age, and comorbid
conditions. We therefore used this sample of patients as
a natural experiment to examine variability in clinical
practice.
The objectives of this study were to determine the
extent to which inter-hospital variability in practice
exists and whether variability in practice is associated
with stroke outcomes. We assessed whether resource
utilization would be similar in such a homogenous
population between two hospitals located in a single
Midwestern US community by comparing use of diag-
nostic testing and associated outcomes following treat-
ment with t-PA.
Methods
Data were collected as part of a larger retrospective,
observational study evaluating the safety and effective-
ness of t-PA use in stroke patients [7]. Study methodol-
ogy is summarized below. The study was approved by
the Institutional Review Boards at the participating
institutions.
Study Design and Setting
Medical records from 206 consecutive patients with
acute ischemic stroke (AIS) treated with IV t-PA in the
emergency departments of two large tertiary care teach-
ing hospitals (one university hospital staffed by medical
school faculty, one community-based staffed by privately
practicing physicians) in Southeastern Michigan were
reviewed. The University Hospital and the Community
Hospital are located within 6 miles of each other. The
two hospitals are similar in size (792 versus 529 beds,
respectively) and adult patient volume (approximately
51,000 versus 65,000 ED visits per year in 2004), and
are the only tertiary care centers within a 30 mile radius.
T h ec o u n t yi nw h i c ht h e s eh ospitals are located has a
population of approximately 300,000 and includes
urban, suburban, and rural areas. Both hospitals have
residency training programs in emergency medicine and
several other specialties. The community hospital does
not have training programs in either neurology or
neurosurgery.
All patients included in this sample presented to the
emergency departments within three hours of onset of
an ischemic stroke. All were administered intravenous t-
PA. All aspects of care were at the discretion of the
treating physicians based on hospital standards.
Case Identification
All patients with AIS treated with t-PA between January
1, 1996 and January 1, 2005 were identified via four
methods (billing data, pharmacy logs, hospital stroke
registries and Paul Coverdell National Acute Stroke reg-
istry data) at each site.
Data Collection
Four clinically trained, National Institutes of Health
Stroke Scale (NIHSS) certified, reviewers (3 RNs, 1 Clin-
ical Ph.D.) abstracted data for each confirmed case from
the paper and/or electronic medical record. Reviewers
were unaware of the hypothesis or analysis presented
here at the time of the chart review. Coding uncertain-
ties were documented and resolved by consensus of the
reviewers with an investigator (PAS or RS). The first
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tional 10% random sample of the remaining records to
assess inter-rater agreement.
Information recorded included, patient demo-
graphics, clinical characteristics, emergency department
and inpatient resource utilization. Specifically, the fre-
quency and use of procedures including computed
tomography (CT), magnetic resonance imaging (MRI)
and magnetic resonance angiography (MRA) of the
brain as well as transthoracic (TTE) and transesopha-
geal (TEE) echocardiography, standard angiography,
and EEG were recorded. Patient oriented outcomes
obtained included presence of any infarct-related
hemorrhage, clinical improvement, hospital length of
stay, discharge location, estimated mRS at discharge
and mortality.
Total hospital LOS was defined as the initial period of
hospitalization from emergency department presentation
to discharge from the acute care hospitalization. Time
in inhospital rehabilitation was not included.
Statistical Analyses
Descriptive statistics are presented. Student’s t-test (con-
tinuous measures) or chi square (proportions) were used
to compare resource utilization and outcomes between
hospitals. All P values were 2-tailed and considered sig-
nificant when less than 0.05.
Results
Sixty-two percent (127) of patients in the study pre-
sented to the community hospital. Baseline demo-
graphics and clinical characteristics of the treated
population in the study are presented in Table 1. Most
baseline patient characteristics, including risk factors for
stroke, were similar between the two hospitals, however,
functional deficits (as measured by an estimated modi-
fied Rankin Scale rating) prior to the onset of stroke
were more common in patients treated at the commu-
nity hospital as compared to the university (34% v. 16%,
p < 0.01). There was no evidence of a difference in
stroke severity based on NIHSS (p > 0.86). The vast
majority of patients had moderate to severe strokes,
with only 5% falling in the mild range (NIHSS ≤ 5).
There was also no difference between hospitals in the
total rate of any intracranial hemorrhage occurring dur-
ing the index admission (p = .712).
In-Hospital Resource Utilization
Utilization of CT scans, as well as non-invasive (ultra-
sound) carotid and transthoracic cardiac imaging were
similar at both hospitals. Brain MRI and MRA, as well
as TEE, and catheter angiography, were used more often
at the university hospital. EEG was obtained more often
at the community hospital (Table 2).
Survival, Length of Stay, Discharge Location and Outcome
There was no significant difference in in-hospital mor-
tality, or survival at one year post-treatment (Table 2).
In the community hospital, 83% (106 of 127) patients
survived to discharge and 70% (89 of 127) to one year.
In the academic hospital 90% (71 of 79) patients sur-
vived to discharge and 75% (59 of 79) to one year.
Hospital LOS was similar between hospitals with an
average of 6.8 days for all patients (Table 2). There were
also no between-hospital differences for LOS when only
patients who survived to discharge were considered. Dis-
charge destination and functional status did not differ.
Abstractors’ estimates of patients’ functional status at
discharge compared to that at admission (i.e., improved
vs. unchanged or worse) also did not differ by hospital
(p = .137).
Data Quality
Double reviews were completed on over 35% of the
charts. Overall raw agreement for all chart abstraction
items including binary, ordinal, continuous, and nominal
Table 1 Patient Baseline Demographic and Clinical
Characteristics by Hospital
Total Community University P
(N = 206) (N = 127) (N = 79)
Age; mean ± stdev 68 ± 15.8 69 ± 15.8 66 ± 15.9 .147
Sex, male; n, (%) 111 (54) 67 (53) 44 (56) .681
Race, Caucasian; n, (%) 179 (87) 109 (86) 70 (89) .358
Pre-Stroke mRS; Median
(IQR)
1 (0-2) 1 (0-2) 0 (0-1) .001
Pre-tx NIHSS;Median (IQR) 13 (8-17) 13 (8-17) 14 (8-17) .867
Intracranial Hemorrhage**;
n, (%)
37 (18) 24 (19) 13 (16) .712
t-PA time*; mean ± stdev 155 ± 33 157 ± 31 151 ± 36 .185
Baseline stroke risk factors n, (%)
Prior Stroke 34 (17) 23 (18) 11 (14) .431
Diabetes 44 (21) 28 (22) 16 (20) .760
Hypertension 142 (69) 92 (72) 50 (63) .168
High cholesterol 66 (32) 41 (32) 25 (32) .924
Hx of coronary artery
disease
65 (32) 41 (32) 24 (30) .775
Hx of congestive heart
failure
20 (10) 13 (10) 7 (9) .746
Hx of atrial fibrillation 58 (28) 34 (27) 24 (30) .576
Smoking w/in 1 year 51 (25) 31 (24) 20 (25) .883
*Time, in minutes, from stroke onset to tPA bolus administration.
**Defined as any intracranial hemorrhage at any time point during the index
hospitalization.
Abbreviations: mRS = modified estimated Rankin Scale; NIHSS = estimated
National Institutes of Health Stroke Scale.
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- 0.976). For the binary and ordinal chart abstraction
items the kappa statistic ranged from 0.49 to 0.96 for
pre-determined critical variables.
Discussion
Consistent with Reed’sf i n d i n g s[ 3 ] ,t h e s ed a t ac o n f i r m
the existence of practice variability in stroke care
between a community hospital and a university hospital,
even in a highly homogenous population of stroke
patients treated with thrombolytic therapy. There was
minimal variability in what can be described as “basic”
d i a g n o s t i ct e s t ss u c ha sC Ti m a g i n g ,c a r o t i dD o p p l e r
imaging, and transthoracic echocardiography. Rather,
care at the university hospital differed from that at the
community hospital with increased frequency of use of
what can be described as “advanced” imaging tests:
MRI, MRA, TEE, and catheter angiography. In addition,
there was increased use of EEG at the community hos-
pital, an uncommon post-stroke diagnostic modality.
Identification of practice variability does not provide
direct evidence of comparative effectiveness across
either populations or in specific individuals. That is, we
have no way of knowing from these data whether more
or fewer diagnostic procedures indicate better or worse
care. On the other hand, it makes sense to look for
variability in care, especially when it involves expensive
modalities and does not have obvious impact on out-
comes, as these are potentially high yield targets for pro-
spective comparative effectiveness research and
reductions in health care expenditures. Practice variabil-
ity had no apparent association with clinical outcome in
these data. The most obvious implication of this infor-
mation is that the increased use of advanced imaging at
the university hospital likely added to the costs of
patient care without adding to patient benefit. A possi-
ble alternative explanation is that there may be benefit
to the increased use of advanced imaging that was sim-
ply too small to detect in these data. Indeed, outcomes
were consistently numerically superior in patients trea-
ted at the university hospital, but these did not reach
statistical significance on any outcome measure.
These associative data do not say anything about the
use of advanced imaging in selected patients. Indeed it
was available and utilized for some patients at both hos-
pitals, but advanced imaging was apparently used more
selectively in the community setting and more liberally
in the university hospital. This difference may reflect the
increased amount of resident decision making in diag-
nostic ordering at the university hospital or possible dif-
ferences over the course of the study in the availability
or access to advanced neurodiagnostic tests between the
two facilities.
It is harder to speculate on why there is higher usage
of EEGs at the community hospital. A detailed examina-
tion of the 13 individuals receiving EEG at the commu-
nity hospital revealed that the indications given for the
study were suspected seizures in three of these patients,
five others had complicated presentations including sig-
nificant psychiatric illness in some cases, and an addi-
tional three were comatose suggesting the EEG may
have been used for prognostic purposes. We cannot
entirely exclude the possibility the increased use of EEG
may reflect collegial pressures to order and utilize intra-
departmental or intra-practice services in this private
practice environment.
Another potential explanation of the variation in test
ordering practices at the two hospitals might be related
to differing degrees of utilization review and differing
effectiveness of cost containment initiatives. The
Table 2 Patient Outcomes and Acute Hospitalization
Resource Utilization by Hospital
Total Community University P
(N = 206) (N = 127) (N = 79)
Tests Performed n, (%)
CT brain 206 (100) 127 (100) 79 (100) 1.000
Follow up CT brain 152 (74) 93 (73) 59 (75) .817
MRI brain 49 (24) 21 (17) 28 (35) .002
MRA brain 35 (17) 11 (9) 24 (30) <.001
MRA neck 38 (18) 20 (16) 18 (23) .205
Carotid Doppler 114 (55) 71 (56) 43 (54) .836
Angiography 17 (8) 6 (4) 11 (13) .020
Transthoracic Echo 58 (28) 31 (24) 27 (34) .130
Transesophageal
Echo
69 (33) 32 (25) 37 (47) .001
EEG 15 (7) 13 (10) 2 (3) .039
Outcomes mean ± stdev
LOS - all (days) 6.75 ± 4.6 6.33 ± 4.3 7.43 ± 5.0 .096
LOS - surviving
(days)
6.91 ± 4.7 6.42 ± 4.4 7.65 ± 4.9 .084
Improved from
admission
154 (75%) 90 (71%) 64 (81%) .137
Discharge destination/
status
n, (%) .302
Home 79 (38) 42 (33) 37 (47)
Inpatient rehab 60 (29) 39 (31) 21 (27)
Other acute care
hosp
4 (2) 2 (2) 2 (3)
Nursing home/assist
living
34 (17) 23 (18) 11 (14)
Death 29 (13) 21 (17) 8 (10)
Abbreviations: CT = computed tomography; MRI = magnetic resonance
imaging; MRA = magnetic resonance angiography; EEG =
electroencephalogram; LOS = length of stay.
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over the age of 65 and thus, likely paid by Medicare via
a Diagnosis-Related Group (DRG) reimbursement sys-
tem. Therefore, it would be expected that the reimbur-
sement rates would be similar between the two
hospitals. It is possible, however, that the community
hospital is more conscious of fiscal issues and thus has
become more efficient at monitoring and controlling
resource use.
Significant strengths of this study design are related to
the homogeneity of patient groups examined as well as
the similarities between the two hospitals allowing a
more true comparison between factors associated with
hospital-specific practice differences without the usual
confounders of differing patient characteristics or even
geographic differences between hospitals and patients.
Another strength is that the chart reviewers were all
clinical personnel with stroke experience, rigorously
trained and provided with clearly defined data defini-
tions and rules for abstraction. This is evidenced by the
high interrater agreement found.
Limitations of this study include those commonly
associated with retrospective chart review. Though these
charts were often particularly detailed due to the use of
thrombolytics, there remain unavoidable problems with
data abstraction. Additionally, the outcome variable of
patient status at discharge compared to that at admis-
sion was subjective and based on the abstractors’ esti-
mates derived from information contained within the
medical chart. Although the patient populations identi-
fied in the two hospitals appear highly homogenous, and
EMS protocols dictate delivery of stroke patients to the
nearest facility independent of other factors, there could
still be unnoticed differences that reflect EMS delivery
of some patients to one hospital rather than the other.
Finally, although a strength in terms of comparison of
two hospitals’ responses to a relatively homogenous
patient group, the sole use of patients presenting with
stroke who were eligible for t-PA potentially limits the
generalizability and conclusions that can be made about
hospital resource utilization in other patient populations.
Conclusion
In summary, practice variability was found between a
c o m m u n i t ya n dau n i v e r s i t yh o s p i t a li nt h ec a r eo fA I S
patients treated with t-PA. There was no apparent asso-
ciation with clinical outcome. These data suggest that
more selective use of advanced imaging in this univer-
sity hospital, and of EEGs in this community hospital,
offers an opportunity for reducing costs and improving
efficiency in the care of stroke patients. Realization of
these improvements may require examining the effects
of organizational culture and fiscal incentives. Lever-
aging the technique of examining homogenous patient
populations may allow identification of systematic ineffi-
ciencies in other disease conditions or healthcare
facilities.
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